SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MulhollandDrive who wrote (631)9/1/1997 2:06:00 PM
From: Henry Niman   of 2173
 
bp, The last 4 posts were definitely ON TOPIC. They address a previous post suggesting that LGND's hormone analogs were somehow different than AMLN's hormone analogs. There is one major difference. LGND's are non-polypeptide hormones so they can be taken in pill form while AMLN's are polypeptide hormones, so they require injection.
However, the post seemed to be implying that AMLN's combinations were somehow safer because they were based on natural hormones. While such compounds may be safer than other drugs, such an arguement is false when applied to the compounds that LGND and WLA are developing in the area of diabetes.
However, both LGND and AMLN are using hormones or analogs of hormones to treat diabetes. LGND of course targets a much wider range of indications, but my posts here are largely focused on diabetes and the hormones used to treat the disease.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News